QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Large accelerated filer |
☐ |
Accelerated filer |
☐ | |||
☒ |
Smaller reporting company |
|||||
Emerging growth company |
Page No. |
||||||
Item 1. |
1 |
|||||
1 |
||||||
2 |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
Item 2. |
24 |
|||||
Item 3. |
29 |
|||||
Item 4. |
29 |
|||||
31 |
||||||
Item 1. |
31 |
|||||
Item 1A. |
31 |
|||||
Item 2. |
31 |
|||||
Item 3. |
31 |
|||||
Item 4. |
31 |
|||||
Item 5. |
31 |
|||||
Item 6. |
34 |
|||||
36 |
September 30, 2021 |
December 31, 2020 |
|||||||
(restated) |
||||||||
Assets |
||||||||
Current assets: |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Other assets |
||||||||
Cash equivalents held in Trust Account |
||||||||
|
|
|
|
|||||
Total Assets |
$ |
$ |
||||||
|
|
|
|
|||||
Liabilities and Shareholders’ Deficit |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | — | |||||
Accrued expenses |
||||||||
Accrued expenses - related party |
||||||||
Working capital loan - related party, at fair value |
— | |||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Deferred underwriting commissions |
||||||||
Derivative warrant liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares September 30, 2021 and December 31, 2020, respectively |
||||||||
Shareholders’ Deficit : |
||||||||
Preference shares, $ |
||||||||
Class A ordinary shares, $ September 30, 2021 and December 30, 2020, respectively |
||||||||
Class B ordinary shares, $ September 30, 2021 and December 31, 2020 |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total shareholders’ deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Liabilities and Shareholders’ Deficit |
$ |
$ |
||||||
|
|
|
|
For the three months ended September 30, 2021 |
For the nine months ended September 30, 2021 |
For the period from July 21, 2020 (inception) through September 30, 2020 |
||||||||||
|
|
|
|
|
|
|
|
( restated ) |
| |||
General and administrative expenses |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ||||||
Other income (expense) |
||||||||||||
Change in fair value of derivative warrant liabilities |
( |
) | — | |||||||||
Financing costs – derivative warrant liabilities |
|
|
— |
|
|
|
— |
|
|
|
( |
) |
Gain on marketable securities (net), and dividends held in Trust Account |
— | |||||||||||
|
|
|
|
|
|
|||||||
Total other income (expense) |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
Weighted average shares outstanding of common stock subject to redemption, basic and diluted |
||||||||||||
|
|
|
|
|
|
|||||||
Basic and diluted net loss per share, common stock subject to redemption |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
Weighted average shares outstanding of common stock, basic and diluted |
||||||||||||
|
|
|
|
|
|
|||||||
Basic and diluted net loss per share, common stock |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
Ordinary Shares |
Additional |
Total |
||||||||||||||||||||||||||
Class A |
Class B |
Paid-in |
Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance - December 31, 2020 (unaudited) (restated) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2021 (unaudited) (restated) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2021 (unaudited) (restated) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2021 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares |
Additional |
Total |
||||||||||||||||||||||||||
Class A |
Class B |
Paid-in |
Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance - July 21, 2020 (inception) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
Issuance of ordinary shares to Sponsor (1) |
— | — | — | |||||||||||||||||||||||||
Remeasurement adjustment on Class A ordinary shares subject to possible redemption |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2020 (restated) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
This number includes |
For the nine months ended September 30, 2021 |
For the period from July 21, 2020 (inception) through September 30, 2020 |
|||||||
(restated) |
||||||||
Cash Flows from Operating Activities: |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Gain on marketable securities (net), and dividends held in Trust Account |
( |
) | — | |||||
Change in fair value of derivative warrant liabilities |
( |
) | — | |||||
Financing costs – derivate warrant liabilities |
|
|
— |
|
|
|
|
|
Expenses paid by sponsor in exchange for working capital loan |
||||||||
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares |
— | |||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
( |
) | ||||||
Accounts payable |
||||||||
Accrued expenses |
||||||||
Accrued expenses – related party |
||||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Cash deposited in Trust Account |
— | ( |
) | |||||
|
|
|
|
|||||
Net cash provided by (used in) investing activities |
( |
) | ||||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from note payable to related party |
— | |||||||
Repayment of note payable to related party |
— | ( |
) | |||||
Proceeds received from initial public offering, gross |
— | |||||||
Proceeds received from private placement |
— | |||||||
Offering costs paid |
— | ( |
) | |||||
|
|
|
|
|||||
Net cash provided by financing activities |
— | |||||||
|
|
|
|
|||||
Net increase in cash |
( |
) | ||||||
Cash - beginning of the period |
— | |||||||
|
|
|
|
|||||
Cash - end of the period |
$ |
$ |
||||||
|
|
|
|
|||||
Supplemental disclosure of noncash investing and financing activities: |
||||||||
Operating expenses paid by Sponsor included in working capital loan |
$ | $ | — | |||||
Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares |
$ | — | $ | |||||
Offering costs included in accounts payable |
$ | — | $ | |||||
Offering costs included in accrued liabilities |
$ | — | $ | |||||
Offering costs included in note payable - related party |
$ | — | $ | |||||
Deferred underwriting commissions |
$ | — | $ | |||||
Remeasurement adjustment on Class A ordinary shares subject to possible redemption |
|
$ |
— |
|
|
$ |
|
|
As of September 21, 2020 |
As Reported |
Adjustment |
As Restated |
|||||||||
Total assets |
$ |
$ |
||||||||||
Total liabilities |
$ |
$ |
||||||||||
Class A ordinary shares subject to possible redemption |
||||||||||||
Preference shares |
||||||||||||
Class A ordinary shares |
( |
) |
||||||||||
Class B ordinary shares |
||||||||||||
Additional paid-in capital |
( |
) |
||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total shareholders’ equity (deficit) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
$ |
$ |
$ |
|||||||||
As of September 30, 2020 |
As Reported |
Adjustment |
As Restated |
|||||||||
Total assets |
$ |
$ |
||||||||||
Total liabilities |
$ |
$ |
||||||||||
Class A ordinary shares subject to possible redemption |
||||||||||||
Preference shares |
||||||||||||
Class A ordinary shares |
( |
) |
||||||||||
Class B ordinary shares |
||||||||||||
Additional paid-in capital |
( |
) |
||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total shareholders’ equity (deficit) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
$ |
$ |
$ |
|||||||||
Statement of changes in Stockholders’ equity for the period from July 21, 2020 (inception) through September 30, 2020 (unaudited) |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Sale of units in initial public offering, gross |
$ |
$ |
( |
) |
$ |
|||||||
Offering costs |
$ |
( |
) |
|||||||||
Remeasurement of Class A ordinary shares subject to possible redemption |
( |
) |
( |
) | ||||||||
Shares subject to possible redemption |
( |
) |
As of December 31, 2020 |
As Reported |
Adjustment |
As Restated |
|||||||||
Total assets |
$ |
$ |
||||||||||
Total liabilities |
$ |
$ |
||||||||||
Class A ordinary shares subject to possible redemption |
||||||||||||
Preference shares |
||||||||||||
Class A ordinary shares |
( |
) |
||||||||||
Class B ordinary shares |
||||||||||||
Additional paid-in capital |
( |
) |
||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total shareholders’ equity (deficit) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
$ |
$ |
$ |
|||||||||
Statement of changes in Stockholders’ equity for the period from July 21, 2020 (inception) through December 31, 2020 (unaudited) |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Sale of units in initial public offering, gross |
$ |
$ |
( |
) |
$ |
|||||||
Offering costs |
$ |
( |
) |
|||||||||
Remeasurement of Class A ordinary shares subject to possible redemption |
( |
) |
( |
) | ||||||||
Shares subject to possible redemption |
( |
) |
As of March 31, 2021 |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Total assets |
$ |
$ |
||||||||||
Total liabilities |
$ |
$ |
||||||||||
Class A ordinary shares subject to possible redemption |
||||||||||||
Preference shares |
||||||||||||
Class A ordinary shares |
( |
) |
||||||||||
Class B ordinary shares |
||||||||||||
Additional paid-in capital |
||||||||||||
Accumulated deficit |
( |
) |
( |
) | ||||||||
Total shareholders’ equity (deficit) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
$ |
$ |
$ |
|||||||||
As of March 31, 2021 |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Shares subject to redemption |
$ |
( |
) |
$ |
$ |
As of June 30, 2021 |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Total assets |
$ |
$ |
||||||||||
Total liabilities |
$ |
$ |
||||||||||
Class A ordinary shares subject to possible redemption |
||||||||||||
Preference shares |
||||||||||||
Class A ordinary shares |
( |
) |
||||||||||
Class B ordinary shares |
||||||||||||
Additional paid-in capital |
( |
) |
||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total shareholders’ equity (deficit) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
$ |
$ |
$ |
|||||||||
As of June 30, 2021 |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Shares subject to redemption |
$ |
$ |
( |
) |
$ |
EPS for Class A ordinary shares (redeemable) |
||||||||||||
As Previously Reported |
Adjustment |
As Restated |
||||||||||
Form 10-Q (March 31, 2021) - three months ended March 31, 2021 |
||||||||||||
Earnings allocable to ordinary shares subject to possible redemption |
$ |
$ |
$ |
|||||||||
Weighted average shares outstanding |
||||||||||||
Basic and diluted earnings per share |
$ |
$ |
$ |
|||||||||
Form 10-Q (June 30, 2021) - three months ended June 30, 2021 |
||||||||||||
Earnings (loss) allocable to ordinary shares subject to possible redemption |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Weighted average shares outstanding |
||||||||||||
Basic and diluted earnings per share |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Form 10-Q (June 30, 2021) - six months ended June 30, 2021 |
||||||||||||
Earnings allocable to ordinary shares subject to possible redemption |
$ |
$ |
$ |
|||||||||
Weighted average shares outstanding |
||||||||||||
Basic and diluted earnings per share |
$ |
$ |
$ |
EPS for Class B ordinary shares (non-redeemable) |
||||||||||||
As Previously Reported |
Adjustment |
As Restated |
||||||||||
Form 10-Q (March 31, 2021) - three months ended March 31, 2021 |
||||||||||||
Earnings allocable to non-redeemable ordinary shares |
$ |
$ |
( |
) |
$ |
|||||||
Weighted average shares outstanding |
( |
) |
||||||||||
Basic and diluted earnings per share |
$ |
$ |
( |
) |
$ |
|||||||
Form 10-Q (June 30, 2021) - three months ended June 30, 2021 |
||||||||||||
Loss allocable to non-redeemable ordinary shares |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Weighted average shares outstanding |
( |
) |
||||||||||
Basic and diluted earnings per share |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Form 10-Q (June 30, 2021) - six months ended June 30, 2021 |
||||||||||||
Earnings allocable to non-redeemable ordinary shares |
$ |
$ |
( |
) |
$ |
|||||||
Weighted average shares outstanding |
( |
) |
||||||||||
Basic and diluted earnings per share |
$ |
$ |
( |
) |
$ |
EPS for Class A ordinary shares (redeemable) |
||||||||||||
As Previously Reported |
Adjustment |
As Restated |
||||||||||
Form 10-Q (September 30, 2020) - the period from July 21, 2020 (inception) through September 30, 2020 |
||||||||||||
Earnings (loss) allocable to ordinary shares subject to possible redemption |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Weighted average shares outstanding |
( |
) |
||||||||||
Basic and diluted earnings per share |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Form 10-K/A (December 31, 2020) - the period from July 21, 2020 (inception) through December 31, 2020 |
||||||||||||
Earnings (loss) allocable to ordinary shares subject to possible redemption |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Weighted average shares outstanding |
( |
) |
||||||||||
Basic and diluted earnings per share |
$ |
$ |
( |
) |
$ |
( |
) |
EPS for Class B ordinary shares (non- redeemable) |
||||||||||||
As Previously Reported, As Restated |
Adjustment |
As Restated |
||||||||||
Form 10-Q (September 30, 2020) - the period from July 21, 2020 (inception) through September 30, 2020 |
||||||||||||
Loss allocable to non-redeemable ordinary shares |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Weighted average shares outstanding |
( |
) |
||||||||||
Basic and diluted earnings per share |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Form 10-K/A (December 31, 2020) - the period from July 21, 2020 (inception) through December 31, 2020 |
||||||||||||
Loss allocable to non-redeemable ordinary shares |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Weighted average shares outstanding |
( |
) |
||||||||||
Basic and diluted earnings per share |
$ |
( |
) |
$ |
$ |
( |
) |
• |
Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
• |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For the Three Months Ended September 30, 2021 |
For the Nine Months Ended September 30, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net loss per common share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average common shares outstanding |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net loss per common share |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
|
|
|
|
|
|
|
|
For the period from July 21, 2020 (inception) through September 30, 2020 |
||||||||
Class A |
Class B |
|||||||
(restated) |
||||||||
Basic and diluted net loss per common share: |
||||||||
Numerator: |
||||||||
Allocation of net loss |
$ |
( |
) |
$ |
( |
) | ||
Denominator: |
||||||||
Basic and diluted weighted average common shares outstanding |
||||||||
|
|
|
|
|||||
Basic and diluted net loss per common share |
$ |
( |
) |
$ |
( |
) | ||
|
|
|
|
Gross Proceeds |
$ | |||
Less: |
— | |||
Offering costs allocated to Class A shares subject to possible redemption |
( |
) | ||
Proceeds allocated to Public Warrants at issuance |
( |
) | ||
Plus: |
||||
Remeasure adjustment on Class A ordinary shares subject to possible redemption amount |
||||
Class A ordinary shares subject to possible redemption |
$ |
|||
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $ |
• | in whole and not in part; |
• | at $ provided |
• | if, and only if, the closing price of Class A ordinary shares equals or exceeds $ |
• | if the closing price of the Class A ordinary shares for any |
September 30, 2021 |
Quoted Prices in Active Markets |
Significant Other Observable Inputs |
Significant Other Unobservable Inputs |
|||||||||
Description |
(Level 1) |
(Level 2) |
(Level 3) |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account |
$ |
$ |
$ |
|||||||||
Liabilities: |
||||||||||||
Warrant liabilities - Public warrants |
$ | $ | $ | |||||||||
Warrant liabilities - Private warrants |
$ | $ | $ | |||||||||
Working capital loan - Related party |
$ | $ | $ |
December 31, 2020 |
Quoted Prices in Active Markets |
Significant Other Observable Inputs |
Significant Other Unobservable Inputs |
|||||||||
Description |
(Level 1) |
(Level 2) |
(Level 3) |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account |
$ | $ | $ | |||||||||
Liabilities: |
||||||||||||
Warrant liabilities - Public warrants |
$ | $ | $ | |||||||||
Warrant liabilities - Private warrants |
$ | $ | $ |
As of September 30, 2021 |
As of December 31 2020 |
|||||||
Stock price |
$ | $ | ||||||
Volatility |
% | % | ||||||
Expected life of the options to convert |
||||||||
Risk-free rate |
% | % | ||||||
Dividend yield |
Derivative warrant liabilities at December 31, 2020 |
$ | |||
Change in fair value of derivative warrant liabilities |
||||
|
|
|||
Derivative warrant liabilities at September 30, 2021 |
$ | |||
|
|
Fair value of working capital loan - related party at December 31, 2020 |
$ |
|||
Initial fair value of working capital loan - related party |
||||
Change in fair value of working capital loan - related party |
— |
|||
|
|
|||
Fair value of working capital loan - related party, September 30, 2020 |
$ |
|||
|
|
• | We have implemented procedures intended to ensure that we identify and apply the applicable accounting guidance to all complex transactions. |
• | We are establishing additional monitoring and oversight controls designed to ensure the accuracy and completeness of our consolidated financial statements and related disclosures. |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||||||||||
104 | Cover Page Interactive Data File |
* | Previously filed |
** | These certifications are not deemed filed by the SEC and are not to be incorporated by reference in any filing we make under the Securities Act of 1933 or the Securities Exchange Act of 1934, irrespective of any general incorporation language in any filings |
ESS TECH, INC. | ||
By: | /s/ Amir Moftakhar | |
Name: | Amir Moftakhar | |
Title: | Chief Financial Officer |